Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Diffusion Pharmaceuticals

NASDAQ DFFN
$9.25 0.58 6.27%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 21 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

18.87M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
8.76M
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
1.54
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
2.04M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events Diffusion Pharmaceuticals

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Diffusion Pharmaceuticals

Stock analysis Diffusion Pharmaceuticals

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
- 28.88
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
0.93 4.03
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-0.11 11.32
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.12 0.25
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-58,829.59 10.75

Price change Diffusion Pharmaceuticals per year

0.46$ 1.85$
Min Max

Summary analysis Diffusion Pharmaceuticals

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Diffusion Pharmaceuticals

Revenue and net income Diffusion Pharmaceuticals

All parameters

Stock news Diffusion Pharmaceuticals

All news
16 December 2022 в 15:35

Diffusion Pharmaceuticals Settles Board Dispute with LifeSci

16 December 2022 в 15:30

Diffusion Pharmaceuticals Settles Board Dispute with LifeSci

About company Diffusion Pharmaceuticals

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company is also developing DFN-529, a phosphoinositide 3-kinase/Akt/mechanistic target of rapamycin pathway inhibitor. Diffusion Pharmaceuticals Inc. was founded in 2001 and is based in Charlottesville, Virginia.
Address:
1317 Carlton Avenue, Charlottesville, VA, United States, 22902
Company name: Diffusion Pharmaceuticals
Issuer ticker: DFFN
ISIN: US2537483057
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2016-01-04
Sector: Healthcare
Industry: Biotechnology
Site: https://www.diffusionpharma.com

On which stock exchange are Diffusion Pharmaceuticals (DFFN) stocks traded?

Diffusion Pharmaceuticals (DFFN) stocks are traded on NASDAQ.

What is the ticker of Diffusion Pharmaceuticals stocks (DFFN)?

The stock ticker of Diffusion Pharmaceuticals’s stocks or in other words, the code is DFFN. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Diffusion Pharmaceuticals (DFFN) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Diffusion Pharmaceuticals (DFFN) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Diffusion Pharmaceuticals (DFFN) stocks traded?

Diffusion Pharmaceuticals (DFFN) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Diffusion Pharmaceuticals (DFFN) stocks today?

The current price of Diffusion Pharmaceuticals stocks on 20.05.2024 is 9.25 dollars. per share.

What is the dynamics of Diffusion Pharmaceuticals (DFFN) stocks from the beginning of the year?

Diffusion Pharmaceuticals (DFFN) quotes have increased by 0% from the beginning of the year up to 9.25 dollars. per 1 stocks.

How much did Diffusion Pharmaceuticals (DFFN) stocks increase in мае 2024?

This month Diffusion Pharmaceuticals (DFFN) quotes have increased by 0% to 9.25 dollars. per share.

How much are Diffusion Pharmaceuticals (DFFN) stocks worth?

Today, on October, 20.05.2024 Diffusion Pharmaceuticals’s (DFFN) stocks cost 9.25 dollars..

What is the market capitalization of Diffusion Pharmaceuticals (DFFN)?

Capitalization is the market value of Diffusion Pharmaceuticals (DFFN) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 20.05.2024, the market capitalization of Diffusion Pharmaceuticals (DFFN) is estimated at about 18870610 dollars.